antigen
Scope
Date
~
-
Bio & Pharma
JLK gets FDA OK for prostate cancer diagnosis AI solution
South Korea’s JLK Inc., an AI-based diagnosis solution and platform maker, announced on Monday that it got approval from the US Food and Drug ...
Jun 25, 2024 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio receives FDA approval for phase 1,2 trials of LCB84
South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...
Jun 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform
Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...
Feb 15, 2023 (Gmt+09:00)
Latest News
- 1 MBK’s Lotte Card sale gains momentum amid Homeplus fallout
- 2 Korean Air, Delta to buy 25% stake in Canada’s WestJet for $550 million
- 3 RedotPay lands in Seoul with crypto cards
- 4 Mubadala, Goldman Sachs to invest $700 mn in Kakao Mobility
- 5 Now, slim is in – and Samsung aims to be No. 1 with Galaxy S25 Edge